<?xml version="1.0" encoding="UTF-8"?>
<p>
 <list list-type="order">
  <list-item>
   <p>A variety of viruses in addition to the classic hepatitis viruses A to E can affect the liver. These include Epstein–Barr virus (EBV), cytomegalovirus (CMV), herpes simplex virus (HSV), varicella zoster virus (VZV), human herpes viruses 6, 7, and 8, human parvovirus B19, adenoviruses, and others.</p>
  </list-item>
  <list-item>
   <p>The clinical presentation of infections with these viruses may be indistinguishable from that associated with the “classic” hepatotropic viruses and can range from transient elevation of aminotransferases to liver failure.</p>
  </list-item>
  <list-item>
   <p>Both the innate and adaptive arms of the immune system play a role in the pathogenesis of virally mediated target organ involvement.</p>
  </list-item>
  <list-item>
   <p>In most immune-competent patients an asymptomatic or mild disease occurs, while immune-suppressed patients and organ transplant recipients are at high risk for the development of severe systemic infection.</p>
  </list-item>
  <list-item>
   <p>Antiviral agents have a role in the treatment of immune-compromised patients and in immune-competent patients who present with severe life-threatening disease.</p>
  </list-item>
  <list-item>
   <p>EBV may be associated with increased risk of malignancy and post-transplant lymphoproliferative disorders (PTLDs).</p>
  </list-item>
 </list>
</p>
